Clinical Trial Update: Efficacy of Intermediate-Dose Cytarabine Induction Regimen in Adult AML [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating whether an intermediate-dose cytarabine induction regimen improves outcomes in adults with acute myeloid leukemia; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Cytarabine (Cytosar-U) (cytarabine)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: AML | Phase 3 | Status: ACTIVE_NOT_RECRUITING